LYELL IMMUNOPHARMA INC
LYELNASDAQ🏆 #2667 by market capEarnings Nov 11US Equity
$14.88▲ $0.57 (+3.84%)
Market closed · at close1h—
24h▲ 3.8%
7d▲ 10.8%
14d▲ 15.1%
30d▲ 3.7%
1y▲ 41.2%
🏦Market Cap
$365M
Small Cap
📈Revenue Growth (YoY)
-41.0%
Declining
📊Gross Margin
-8537.0%
Thin
💵FCF Margin
-639148.2%
Thin
⚖️P/S Ratio
13504.6x
Expensive
Otter Score
42
Weak
📊
Analyst Ratings
Price
$14.88
Total
7
Raised
0
Lowered
3
Avg PT
$47.00
H / L
$49 / $45
| Institution | Action | Rating | Date |
|---|---|---|---|
Citizens | Reiterated | Market Outperform | 2026-06-15 |
Needham | Reiterated | Buy | 2026-06-15 |
HC Wainwright & Co. | Reiterated | Buy | 2026-06-09 |
B of A Securities | Downgraded | Buy → Underperform | 2024-10-30 |
JP Morgan | Downgraded | Overweight → Neutral | 2023-08-28 |
Morgan Stanley | Reiterated | Equal Weight | 2023-01-24 |
Goldman Sachs | Downgraded | Buy → Neutral | 2022-11-11 |
One row per institution, most recent rating